FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 51 through 100 of 163

PHARMACEUTICAL PREPARATIONS - SIC # 2834

Ticker Exchange Company Financial Reports SIC #
EOLS Nasdaq Evolus, Inc. 2834
EPRX Nasdaq Eupraxia Pharmaceuticals Inc. 2834
ESAIY Over the counter Eisai Co., Ltd. 2834
EVMN New York Evommune, Inc. 2834
GDTC Nasdaq CytoMed Therapeutics Limited 2834
GLTO Nasdaq Galecto, Inc. 2834
GNLX Nasdaq Genelux Corporation 2834
GRI Nasdaq GRI Bio, Inc. 2834
GYRE Nasdaq Gyre Therapeutics, Inc. 2834
HCM Nasdaq HUTCHMED (China) Limited 2834
IDYA Nasdaq IDEAYA Biosciences, Inc. 2834
IMRN Nasdaq Immuron Limited 2834
IMTX Nasdaq Immatics N.V. 2834
IMVT Nasdaq Immunovant, Inc. 2834
INVA Nasdaq Innoviva, Inc. 2834
IOBT Nasdaq IO Biotech, Inc. 2834
IPSEY Over the counter Ipsen S.A. 2834
ITRM Nasdaq Iterum Therapeutics plc 2834
IVA Nasdaq Inventiva S.A. 2834
JANX Nasdaq Janux Therapeutics, Inc. 2834
JNJ New York Johnson & Johnson 2834
KAPA NYSE American Kairos Pharma, Ltd. 2834
KLTO Nasdaq Klotho Neurosciences, Inc. 2834
KNSA Nasdaq Kiniksa Pharmaceuticals International, p 2834
KPRX Nasdaq Kiora Pharmaceuticals, Inc. 2834
KPTI Nasdaq Karyopharm Therapeutics Inc. 2834
KURA Nasdaq Kura Oncology, Inc. 2834
KYKOY Over the counter Kyowa Kirin Co., Ltd. 2834
LBRX Nasdaq LB Pharmaceuticals Inc 2834
LLY New York Eli Lilly and Company 2834
LZAGY Over the counter Lonza Group AG 2834
MAIA NYSE American MAIA Biotechnology, Inc. 2834
MBRX Nasdaq Moleculin Biotech, Inc. 2834
MCRB Nasdaq Seres Therapeutics, Inc. 2834
MDGL Nasdaq Madrigal Pharmaceuticals, Inc. 2834
MLTX Nasdaq MoonLake Immunotherapeutics 2834
MTVA Nasdaq MetaVia Inc. 2834
MXCT Nasdaq MaxCyte, Inc. 2834
NBIX Nasdaq Neurocrine Biosciences, Inc. 2834
NKTX Nasdaq Nkarta, Inc. 2834
NTHI Nasdaq NeOnc Technologies Holdings, Inc. 2834
NTLA Nasdaq Intellia Therapeutics, Inc. 2834
NTRB Nasdaq Nutriband Inc. 2834
NVAX Nasdaq Novavax, Inc. 2834
NVS New York Novartis AG 2834
OCGN Nasdaq Ocugen, Inc. 2834
OCUL Nasdaq Ocular Therapeutix, Inc. 2834
ORGO Nasdaq Organogenesis Holdings Inc. 2834
ORMP Nasdaq Oramed Pharmaceuticals Inc. 2834
ORXOY Over the counter Orexo AB (publ) 2834
Results 50 through 100 of 163